Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Popper & Sons, Inc. — Predicate Candidate Screening

8 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

52 daysmedian FDA review time
67 days90th percentile
8clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K911397HYPODERMIC NEEDLES, SINGLE LUMENPopper & Sons, Inc.1991-05-20520
K843830J -JAMSHIDI TYPE-BONE MARROW BIOPSY/ASPIPopper & Sons, Inc.1984-10-26250
K843690ILLINOIS STERNUM/ILIAC ASPIRATION NEEDLEPopper & Sons, Inc.1984-10-25360
K842406WESCOTT TYPE BIOPSY NEEDLEPopper & Sons, Inc.1984-08-09510
K841301GARDNER TYPE BONE MARROW NEEDLEPopper & Sons, Inc.1984-06-05670
K841300ANTRUM NEEDLE-WOLF TYPEPopper & Sons, Inc.1984-06-05670
K841299BIERMAN BIOPSY NEEDLEPopper & Sons, Inc.1984-05-02330
K840168WESTERMAN-JENSEN BIOPSY NEEDLEPopper & Sons, Inc.1984-03-12560

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda